Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
Type III (pauci-immune RPGN): glomerulonephritis is associated with few or no immune deposits by immunofluorescence or electron microscopy (50% of cases; up to 90% of patients are ANCA positive).
Laboratory Findings
Laboratory workup is urgent to initiate therapy since untreated patients progress rapidly to ESRD. Renal biopsy findings establish the diagnosis and prognosis.
Urinalysis
Oliguria, with urine volume often <400 mL/day.
Gross hematuria: RBCs, WBCs, RBC casts.
Proteinuria starts approximately 3 days after injury and may not be marked because of the severe reduction in GFR.
Rapid, progressive rise in creatinine and BUN.
Laboratory tests to determine underlying etiology (e.g., ANCA, anti-GBM antibodies, antinuclear antibodies) can be helpful. Other tests include serology testing for HIV and hepatitis B and C.
HEPATORENAL SYNDROME
Definition
Progressive renal failure that develops in patients with decompensated liver cirrhosis or fulminant hepatic failure.
Classified as
Type I: serum creatinine increases to >2.5 mg/dL within 2 weeks
Type II: less severe and associated with gradual increase in serum creatinine (1.5–2.5 mg/dL) over few weeks or months